다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Coherus BioSciences Inc (CHRS)
Coherus BioSciences Inc (CHRS) 뉴스

CHRS

Coherus BioSciences (CHRS)

Coherus BioSciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CHRS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/30	22:00	GlobeNewswire Inc.	Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/24	06:51	GlobeNewswire Inc.	Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/23	22:00	GlobeNewswire Inc.	Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/22	06:14	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/14	05:35	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/10	05:51	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/10	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/10	05:01	GlobeNewswire Inc.	Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/09	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/09	20:30	GlobeNewswire Inc.	Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/08	22:00	GlobeNewswire Inc.	Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer	NASDAQ:CHRS	Coherus BioSciences Inc
2024/05/02	05:30	GlobeNewswire Inc.	Coherus to Report First Quarter 2024 Financial Results on May 9, 2024	NASDAQ:CHRS	Coherus BioSciences Inc
2024/04/24	23:02	GlobeNewswire Inc.	Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:CHRS	Coherus BioSciences Inc
2024/04/08	21:30	GlobeNewswire Inc.	Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting	NASDAQ:CHRS	Coherus BioSciences Inc
2024/03/14	05:01	GlobeNewswire Inc.	Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update	NASDAQ:CHRS	Coherus BioSciences Inc
2024/03/06	06:01	GlobeNewswire Inc.	Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	NASDAQ:CHRS	Coherus BioSciences Inc
2024/03/04	20:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CHRS	Coherus BioSciences Inc
2024/03/04	15:00	GlobeNewswire Inc.	Coherus Completes Divestiture of Ophthalmology Franchise	NASDAQ:CHRS	Coherus BioSciences Inc
2024/02/24	07:33	GlobeNewswire Inc.	Coherus BioSciences Announces New Employment Inducement Grants	NASDAQ:CHRS	Coherus BioSciences Inc
2024/02/23	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CHRS	Coherus BioSciences Inc
2024/02/23	07:00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CHRS	Coherus BioSciences Inc
2024/02/23	06:59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CHRS	Coherus BioSciences Inc
2024/02/21	22:30	GlobeNewswire Inc.	Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv	NASDAQ:CHRS	Coherus BioSciences Inc
2024/02/05	22:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CHRS	Coherus BioSciences Inc
2024/02/05	22:00	GlobeNewswire Inc.	Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP	NASDAQ:CHRS	Coherus BioSciences Inc
2024/01/24	10:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CHRS	Coherus BioSciences Inc
2024/01/24	10:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CHRS	Coherus BioSciences Inc
2024/01/22	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CHRS	Coherus BioSciences Inc
2024/01/22	15:59	Dow Jones News	Sandoz to Acquire Cimerli Business from Coherus for $170 Million	NASDAQ:CHRS	Coherus BioSciences Inc
2024/01/22	15:15	GlobeNewswire Inc.	Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in $170 Million Upfront All Cash Deal	NASDAQ:CHRS	Coherus BioSciences Inc

검색 관련기사 보기:NASDAQ:CHRS

1 2 3 4 5 6 7 8 9 10 다음 >>

FSDV Sarreguemines

Genius Metals (PK)

DAX Risk Control 15% RV ...

DI1F36 - Janeiro 2036

Banco Santander

VANECK VETH INAV

A91 Partners Fund Ii

Brookstone Opportunities...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관